guest ::
| Home > Publications database > miR-137 inhibits proliferation of melanoma cells by targeting PAK2. > print |
| Home > Publications database > miR-137 inhibits proliferation of melanoma cells by targeting PAK2. > print |
| 001 | 126665 | ||
| 005 | 20240228140840.0 | ||
| 024 | 7 | _ | |a 10.1111/exd.12812 |2 doi |
| 024 | 7 | _ | |a pmid:26186482 |2 pmid |
| 024 | 7 | _ | |a 0906-6705 |2 ISSN |
| 024 | 7 | _ | |a 1600-0625 |2 ISSN |
| 024 | 7 | _ | |a altmetric:4291161 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2017-02693 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Hao, Shuai |b 0 |
| 245 | _ | _ | |a miR-137 inhibits proliferation of melanoma cells by targeting PAK2. |
| 260 | _ | _ | |a Oxford |c 2015 |b Wiley-Blackwell |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1523949563_20742 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a MicroRNAs (miRNA) are key players in a variety of cancers including malignant melanoma. miR-137 has been reported to be a tumor suppressor in melanoma and several targets have been identified for this miRNA. We previously developed a novel proteomics technology, (35) S in vivo/vitro labelling analysis for dynamic proteomics (SiLAD). Because of its high sensitivity in analysing protein expression rates, SiLAD has the potential to unravel miRNA effects on mRNAs coding for proteins with long half-lives or high abundance. Using SiLAD, we discovered that miR-137 significantly downregulated the expression rate of p21-activated kinase 2 (PAK2) in melanoma cells. Bioinformatics analysis predicted PAK2 as a direct target of miR-137, which was confirmed by luciferase reporter assay and Western blot analysis. We found that overexpression of miR-137 inhibited the proliferation of melanoma cells, which could be phenocopied by knockdown of PAK2 using siRNAs. Furthermore, overexpression of PAK2 restored miR-137-mediated suppression of cell proliferation. These findings indicate that miR-137 could inhibit proliferation through targeting PAK2 in melanoma cells. |
| 536 | _ | _ | |a 317 - Translational cancer research (POF3-317) |0 G:(DE-HGF)POF3-317 |c POF3-317 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a MIRN137 microRNA, human |2 NLM Chemicals |
| 650 | _ | 7 | |a MicroRNAs |2 NLM Chemicals |
| 650 | _ | 7 | |a RNA, Neoplasm |2 NLM Chemicals |
| 650 | _ | 7 | |a RNA, Small Interfering |2 NLM Chemicals |
| 650 | _ | 7 | |a PAK2 protein, human |0 EC 2.7.11.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a p21-Activated Kinases |0 EC 2.7.11.1 |2 NLM Chemicals |
| 700 | 1 | _ | |a Luo, Chonglin |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Abukiwan, Alia |0 P:(DE-He78)ee782484657011f0081a1425afa47a3f |b 2 |u dkfz |
| 700 | 1 | _ | |a Wang, Guangxia |b 3 |
| 700 | 1 | _ | |a He, Jinjun |b 4 |
| 700 | 1 | _ | |a Huang, Lingyun |b 5 |
| 700 | 1 | _ | |a Weber, Claudia E M |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Lv, Na |b 7 |
| 700 | 1 | _ | |a Xiao, Xueyuan |b 8 |
| 700 | 1 | _ | |a Eichmüller, Stefan B |0 0000-0002-3497-6904 |b 9 |
| 700 | 1 | _ | |a He, Dacheng |b 10 |
| 773 | _ | _ | |a 10.1111/exd.12812 |g Vol. 24, no. 12, p. 947 - 952 |0 PERI:(DE-600)2026228-0 |n 12 |p 947 - 952 |t Experimental dermatology |v 24 |y 2015 |x 0906-6705 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:126665 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)ee782484657011f0081a1425afa47a3f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 0000-0002-3497-6904 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-317 |2 G:(DE-HGF)POF3-300 |v Translational cancer research |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EXP DERMATOL : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-He78)G183-20160331 |k G183 |l Präklinische T-Zellforschung |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)G183-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|